Latest filing published 18 Sept 2026 for Oscar Health, Inc.. Read the official filing
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Joshua Kushner in Oscar Health, Inc., where the filings describe the role as chief executive. The record holds 18 filings, for trades running from 20 August 2021 to 18 September 2026.
The open-market record is one-sided, with 10 purchases worth €27.5M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €2.6M. 9 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 6 purchases show a median change of -31.0%, with the price up in 0% of them. This is a record of the past, not a forecast.
The newest entry dates from 18 September 2026: a transaction, in Oscar Health, Inc. The most recent open-market purchase was published on 22 November 2024, 695 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Thrive Partners VII Growth GP, LLC, counted once · View ↗
Same trade as the filing by Thrive Partners VII Growth GP, LLC, counted once · View ↗
Same trade as the filing by Thrive Partners VII Growth GP, LLC, counted once · View ↗
17 of 14 declarations